| Literature DB >> 30914298 |
Zahra Karami1, Mohammad Reza Saghatchi Zanjani1, Mehrdad Hamidi2.
Abstract
Despite enormous efforts, treatment of CNS diseases remains challenging. One of the main issues causing this situation is limited CNS access for the majority of drugs used as part of the therapeutic regimens against life-threatening CNS diseases. Regarding the inarguable position of the nanocarrier systems in neuropharmacokinetic enhancement of the CNS drugs, this review discusses the latest findings on nanoemulsions (NEs) as one of the most promising candidates of this type, to overcome the challenges of CNS drug delivery. Future development of NE-based CNS drug delivery needs to consider so many aspects not only from a physicochemical point of view but also related to the biointerface of these very small droplets before achieving clinical value.Entities:
Mesh:
Substances:
Year: 2019 PMID: 30914298 DOI: 10.1016/j.drudis.2019.03.021
Source DB: PubMed Journal: Drug Discov Today ISSN: 1359-6446 Impact factor: 7.851